Dynamics of peripheral immune cells and their HLA‐G and receptor expressions in a patient suffering from critical COVID‐19 pneumonia to convalescence

Sheng Zhang,Jun Gan,Bao‐Guo Chen,Dan Zheng,Jian‐Gang Zhang,Rong‐Hai Lin,Yi‐Ping Zhou,Wei‐Ying Yang,Aifen Lin,Wei‐Hua Yan
DOI: https://doi.org/10.1002/cti2.1128
2020-01-01
Abstract:OBJECTIVES: Host immune responses are indispensable to combat the disease. We report the dynamics of peripheral immune cells, cytokines, and human leucocyte antigen-G (HLA-G) and its receptor expressions in a patient suffering from critical COVID-19 pneumonia to convalescence.METHODS: Clinical data of the patient were collected from medical records. The expressions of HLA-G and receptors ILT2, ILT4 and KIR2DL4 in peripheral immune cells were measured with flow cytometry.RESULTS: From critical COVID-19 to the convalescent stage, early lymphopenia was improved (median: 0.6 × 10<sup>9</sup> L<sup>-1</sup> vs. 0.9 × 10<sup>9</sup> L<sup>-1</sup>, <i>P</i> = 0.009), and an obvious fluctuation in WBC and neutrophil counts was observed. Initially, low levels of CD4<sup>+</sup> T cells (from 120 to 528 μL<sup>-1</sup>) and CD8<sup>+</sup> T cells (from 68 to 362 μL<sup>-1</sup>) gradually increased to normal levels. Meanwhile, high IL-6 (from 251.8 to 6.32 pg mL<sup>-1</sup>), IL-10 (from 39.53 to 5.21 pg mL<sup>-1</sup>) and IFN-γ (from 13.55 to 3.16 pg mL<sup>-1</sup>) levels decreased, and IL-4 (from 2.36 to 3.19 pg mL<sup>-1</sup>) and TNF-α (from 2.27 to 20.2 pg mL<sup>-1</sup>) levels increased quickly when the viral RNA returned negative. Moreover, the percentage of HLA-G<sup>+</sup> T cells, B cells and monocytes follows high-low-high pattern, while the percentage of receptors ILT2-, ILT4- and KIR2DL4-expressing cells remained relatively stable.CONCLUSION: Our findings provide valuable information on the dynamics of early peripheral immunological responses in SARS-CoV-2 infection. CD4<sup>+</sup> and CD8<sup>+</sup> T cells, cytokines and HLA-G<sup>+</sup> immune cells are associated with the natural history of the critical COVID-19 patient; however, future studies are necessary.
immunology
What problem does this paper attempt to address?